IA
ANIK icon

IFP Advisors’s Anika Therapeutics ANIK Stock Holding History

IFP Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23K Buy
289
+258
+832% +$3.82K ﹤0.01% 3882
2026
Q1 		$450 Sell
31
-34
-52% -$395 ﹤0.01% 4444
2025
Q4 		$625 Buy
65
+42
+183% +$402 ﹤0.01% 4221
2025
Q3 		$216 Buy
+23
New +$220 ﹤0.01% 4382
2025
Q2 		– Sell
-4
Closed -$50 – 4725
2025
Q1 		$60 Hold
4
– – ﹤0.01% 3983
2024
Q4 		$66 Buy
+4
New +$79 ﹤0.01% 4167
2023
Q1 		– Sell
-17
Closed -$3K – 3395
2022
Q4 		$3K Buy
+17
New +$484 ﹤0.01% 3972
2021
Q1 		– Sell
-37
Closed -$1.4K – 3003
2020
Q4 		$2K Buy
+37
New +$1.4K ﹤0.01% 2582
2018
Q2 		– Sell
-225
Closed -$12K – 3862
2018
Q1 		$12K Hold
225
– – ﹤0.01% 2659
2017
Q4 		$12K Hold
225
– – ﹤0.01% 2696
2017
Q3 		$13K Buy
+225
New +$11.8K ﹤0.01% 2864
2017
Q1 		– Sell
-740
Closed -$36K – 3976
2016
Q4 		$36K Buy
740
+40
+6% +$1.85K ﹤0.01% 2067
2016
Q3 		$33K Sell
700
-440
-39% -$21.7K ﹤0.01% 2069
2016
Q2 		$61K Buy
+1,140
New +$53.7K ﹤0.01% 1648
2016
Q1 		– Sell
-20
Closed -$1K – 2397
2015
Q4 		$1K Buy
+20
New +$765 ﹤0.01% 3473

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

IFP Advisors's ANIK Position: Q2 2026 in Review

IFP Advisors increased its Anika Therapeutics (ANIK) stake by 832% in Q2 2026, buying an estimated $3.82K and bringing the position to 289 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3882.

IFP Advisors first reported a position in ANIK in Q4 2015 and has held it in 15 quarters since. The position peaked at $61K in Q2 2016. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • IFP Advisors held 289 shares of Anika Therapeutics worth $4.23K as of Q2 2026.
  • IFP Advisors bought 258 Anika Therapeutics shares in Q2 2026, an estimated $3.82K.
  • Anika Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3882 holding.
  • IFP Advisors first reported a position in Anika Therapeutics in Q4 2015 and has held it in 15 quarters since.
  • IFP Advisors's Anika Therapeutics position peaked at $61K in Q2 2016.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.